Pharming CEO Chouraqui steps down; names Marsh, Lynard interim co-CEOs

By Public Technologies
  • Pharming announced CEO and executive director Fabrice Chouraqui stepped down with immediate effect.
  • Chief Commercial Officer Leverne Marsh named interim co-CEO to run patient-focused operations.
  • Chief Financial Officer Kenneth Lynard named interim co-CEO to oversee global corporate functions.
  • Board launched a formal search for a permanent CEO successor.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharming Group NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290100OMX_____CNEWS_EN_GNW1001275065_en) on September 29, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk